# Gap Analysis: PDF Requirements vs. FSH Implementation
**KDS-Modul Seltene Erkrankungen**

*Generated: 2025-07-31*

## Executive Summary

This analysis compares the information model requirements from the official PDF document against the current FSH profile implementation. The current implementation covers approximately **30%** of the PDF requirements, with significant gaps in measurement profiles, therapy modules, and temporal extensions.

## 1. Coverage Overview

| Category | PDF Requirements | FSH Implementation | Coverage |
|----------|------------------|-------------------|----------|
| HPO Phenotyping | ✅ Complete | ✅ Well implemented | 90% |
| Diagnosis Profiles | ✅ Complete | ⚠️ Partial | 70% |
| Family History | ✅ Complete | ✅ Well implemented | 85% |
| Measurements | ✅ Complete | ❌ Major gaps | 20% |
| Therapy & Research | ✅ Complete | ❌ Not implemented | 0% |
| Clinical Context | ✅ Complete | ⚠️ Partial | 40% |

## 2. Well-Implemented Components ✅

### 2.1 HPO Assessment (`mii-pr-se-hpo-assessment.fsh`)
- **PDF Requirement**: HPO-Term, HPO-Status, phenotypic observations
- **Implementation**: Complete FHIR Observation profile with:
  - HPO codes for phenotypic observations
  - Severity values (mild, moderate, severe)
  - Boolean presence/absence indicators
  - Effective date/period tracking
  - Body site specification

### 2.2 Diagnosis Profile (`mii-pr-se-diagnosis.fsh`)
- **PDF Requirement**: Rare disease diagnosis with multiple coding systems
- **Implementation**: Well-structured Condition profile with:
  - ORPHA, OMIM, SNOMED CT coding support
  - Syndrome category extension
  - Phenotypic pattern extension
  - Onset age extension (R5 backport)

### 2.3 Family History (`mii-pr-se-familienanamnese.fsh`)
- **PDF Requirement**: Biological relationships with disease status
- **Implementation**: Inherits from MolGen profile with:
  - SNOMED relationship hierarchy
  - Multiple coding systems (ICD-10-GM, Alpha-ID, ORPHA)
  - "von SE betroffen" extension for affected family members

### 2.4 Waist-to-Hip Ratio (`WaistToHipRatio.fsh`)
- **PDF Requirement**: Anthropometric measurement for rare diseases
- **Implementation**: LOINC-based Observation with proper UCUM units

## 3. Major Implementation Gaps ❌

### 3.1 Measurement Profiles (Critical Gap)

#### Missing BMI Profile
- **PDF Requirement**: `Messbefunde: BMI` (Float, 0..1) with date
- **Status**: ❌ Not implemented
- **Note**: PDF states "BMI als abgeleiteter Datenwert im Modul Intensivmedizin nicht vorhanden"
- **Impact**: Essential for rare disease phenotyping

#### Missing Anthropometric Components
- **PDF Requirements**:
  - Taillenumfang (Waist circumference) in cm
  - Hüftumfang (Hip circumference) in cm
- **Status**: ❌ Not implemented
- **Note**: Waist-to-hip ratio exists but component measurements missing

#### Missing Blood Group Profile
- **PDF Requirement**: `Messbefunde: Blutgruppe` - AB0 + Rh factor
- **Status**: ❌ Not implemented
- **Recommendation**: Base on LOINC Panel 34530-6
- **Impact**: Important for certain rare diseases

### 3.2 Therapy & Research Module (Complete Gap)

#### Therapy Recommendations
- **PDF Requirements**:
  - `Therapieempfehlung: Art` (0..N)
  - Categories: Pharmakotherapie, Gentherapie, mRNA Therapie, CAR-T-Zelltherapie, etc.
  - Off-label-Gabe status (Ja/Nein/Unbekannt)
- **Status**: ❌ Completely missing
- **Suggested Implementation**: CarePlan profile

#### Performed Therapies
- **PDF Requirements**:
  - `Durchgeführte Therapien: Art` (0..N)
  - Start/end dates with reason for termination
  - Off-label medication tracking
- **Status**: ❌ Completely missing
- **Suggested Implementation**: MedicationStatement + Procedure profiles

#### Study Participation
- **PDF Requirements**:
  - Studien-ID (national/international)
  - Study status (Abgeschlossen, Fortlaufend)
  - Study period tracking
- **Status**: ❌ Completely missing
- **Note**: Should integrate with "Modul Medizinische Forschungsvorhaben"

### 3.3 Diagnosis Timing Extensions

#### Clinical Diagnosis Timing
- **PDF Requirements**:
  - `Zeitpunkt klinische Diagnose SE` (life phase selection)
  - `Feststellungsdatum klinische Diagnose SE` (actual date)
  - `Alter klinische Diagnose SE` (age at diagnosis)
- **Status**: ❌ Not implemented

#### Genetic Diagnosis Timing
- **PDF Requirements**:
  - `Zeitpunkt genetische Diagnose SE` (life phase selection)
  - `Feststellungsdatum genetische Diagnose SE` (actual date)
  - `Alter genetische Diagnose SE` (age at genetic diagnosis)
- **Status**: ❌ Not implemented

#### Diagnosis Methods
- **PDF Requirements**:
  - `Methode der Diagnosestellung` (0..*)
  - Options: (Molekular-) Genetik, klinischer Phänotyp, Bildgebung, Histopathologie, etc.
  - `Genetische Diagnose mit fehlender Penetranz` (Ja/Nein/Unbekannt)
- **Status**: ❌ Not implemented

### 3.4 Investigation Context

#### Clinical Assessment Context
- **PDF Requirements**:
  - `Untersuchungsdatum` (Date, 0..1)
  - `Untersuchungsanlass` (Code, 0..1): Erstvorstellung, Besprechung Diagnostik, Verlaufsdiagnostik
- **Status**: ❌ Not implemented
- **Impact**: Clinical impressions lack proper context

### 3.5 Death Information

#### Mortality Data
- **PDF Requirements**:
  - `An SE verstorben` (Ja/Nein/Unbekannt)
  - `Andere Todesursache` (ICD-10-GM, Alpha-ID, ORPHA codes)
- **Status**: ❌ Not implemented
- **Note**: Death date exists in MII Person, but SE-specific death causes missing

## 4. Partial Implementations ⚠️

### 4.1 Symptom Condition (`mii-pr-se-symptom-condition.fsh`)
- **Implemented**: HPO-based coding, temporal constraints
- **Missing**:
  - Life phase extensions (`Lebensphase Symptom`)
  - Symptom progression tracking (`Verlauf des Symptoms`)
  - HPO version tracking (`HPO-Version`)

### 4.2 Clinical Impression (`mii-pr-se-clinical-impression.fsh`)
- **Implemented**: Basic structure for clinical assessments
- **Missing**: Investigation reason/context integration

## 5. Implementation Roadmap

### Phase 1: Critical Gaps (High Priority)
1. **Create BMI and Anthropometric Profiles**
   - BMI Observation profile
   - Waist/hip circumference profiles
   - Blood group profile (LOINC Panel 34530-6)

2. **Implement Therapy Module**
   - CarePlan profile for therapy recommendations
   - MedicationStatement profile for performed therapies
   - Extensions for off-label use tracking

3. **Add Diagnosis Timing Extensions**
   - Clinical diagnosis timing extensions
   - Genetic diagnosis timing extensions
   - Diagnosis method extensions

### Phase 2: Enhanced Functionality (Medium Priority)
1. **Investigation Context Enhancement**
   - Enhance ClinicalImpression with investigation reason
   - Add temporal context for clinical assessments

2. **HPO Temporal Extensions**
   - Life phase tracking
   - Symptom progression indicators
   - HPO version management

3. **Study Participation Integration**
   - Research participation profiles
   - Integration with MII research module

### Phase 3: Advanced Features (Lower Priority)
1. **Enhanced Family History**
   - Additional penetrance details
   - Family member death status tracking

2. **Mortality Information**
   - SE-specific death cause tracking
   - Enhanced death information profiling

## 6. Required Extensions

### New Extensions Needed
```fsh
// Diagnosis-related
Extension: DiagnosisMethod
Extension: ClinicalDiagnosisTiming  
Extension: GeneticDiagnosisTiming
Extension: MissingPenetrance

// Clinical Context
Extension: InvestigationReason
Extension: InvestigationDate

// Therapy-related
Extension: OffLabelUse
Extension: TherapyEndReason
Extension: StudyParticipation

// Temporal
Extension: HPOVersion
Extension: SymptomProgression
```

## 7. Integration with Existing MII Modules

| MII Module | Current Usage | Required Enhancements |
|------------|---------------|----------------------|
| Person | Basic demographics | SE-specific death information |
| Diagnosis | Base diagnosis | Timing and method extensions |
| MolGen | Family history base | Already well integrated |
| Laboratory | Not used | Blood group implementation |
| ICU | Not used | BMI profile creation needed |
| Research | Not used | Study participation integration |

## 8. Quality Assurance Notes

### Standards Compliance
- All profiles follow MII naming conventions
- FHIR R4 compliance maintained
- German localization implemented
- Proper LOINC/SNOMED CT usage where applicable

### Missing Standards Usage
- Some value sets use HL7 v2 codes instead of LOINC/SNOMED CT
- Therapy classifications need standardized code systems
- Investigation reasons need proper value set

## 9. Recommendations

### Immediate Actions
1. **Prioritize measurement profiles** - Essential for clinical documentation
2. **Implement therapy module** - Critical gap for comprehensive care documentation  
3. **Add diagnosis timing** - Required for NARSE/ERDRI-CDS compliance

### Long-term Strategy
1. **Coordinate with other MII modules** for overlapping functionality
2. **Plan for HL7 balloting process** mentioned in PDF
3. **Ensure NARSE/ERDRI-CDS/MV GenomSeq mapping** as specified

### Risk Mitigation
- Current 30% coverage may impact clinical adoption
- Missing therapy documentation limits care coordination
- Incomplete measurement profiles affect research data quality

---

*This analysis was generated by comparing the official PDF information model (2025-07-03_IOP_KDS_Modul_Seltene_Erkrankungen_InfModell.pdf) against the current FSH implementation in the repository.*